“…Most insulin-treated diabetics develop insulin antibodies which influence insulin action (Keilacker et al, 1982; and insulin pharmacodynamics (Kurtz et aI., 1977;Havford and Thompson, 1982;Francis et al, 1985;Waldhäusl et al, 1985;Madsbad et al, 1985;Sodoyez et al, 1984). In these patients injected insulin distributes between an antibody-bound and a non-bound compartment (free insulin), the latter being considered as representing the biologically active form of the administered insulin, although, under certain conditions, antibody-bound insulin may also act on target cells (Keilacker et al, 1985). Accordingly, in insulin-treated patients serum insulin is determined as either free insulin in polyethylene glycol extracted serum (Nakagawa et al, 1973;Gennaro and van Norman, 1975;Kuzuya et al, 1976) or total (free plus bound) insulin in ethanol (Ohneda et al, 1970;Heding, 1972;Ziegler et al, 1975;Martin and Russe!, 1974;Davidson and Deal, 1976) or polyethylene glycol (Nakagawa et al, 1973;Gennaro and van Norman, 1975;Kuzuya et al, 1976) extracted serum after preceding acidification.…”